Expression of VEGF, EGFR, and IL-6 in gastric adenomas and adenocarcinomas by endoscopic submucosal dissection

Digestive Diseases and Sciences

Volumn 55, Issue 7, 2010, Pages 1955-1963

  Lee, Shin Ae ^a   Choi, Seok Reyol ^a   Jang, Jin Seok ^a   Lee, Jong Hun ^a   Roh, Myung Hwan ^a   Kim, Sang Ock ^a   Kim, Min Chan ^b   Kim, Su Jin ^a   Jeong, Jin Sook ^a  

^a Dong A University   (South Korea)

^b Dong A University College of Medicine   (South Korea)

Author keywords

EGC; EGFR; ESD; Gastric adenoma; IL 6; VEGF

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 6; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DYSPLASIA; ENDOSCOPIC SUBMUCOSAL DISSECTION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; COHORT STUDIES; FEMALE; GASTRIC MUCOSA; GASTROSCOPY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MALE; MIDDLE AGED; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77954421723     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0967-1     Document Type: Article

References (40)

1. J Folkman 1990 What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82 4 6 10.1093/jnci/82.1.4 1688381
2. M Tomoda Y Maehara Y Kakeji S Ohno Y Ichiyoshi K Sugimachi 1999 Intratumoralneovascularization and growth pattern in early gastric carcinoma Cancer 85 2340 2346 10.1002/(SICI)1097-0142(19990601)85:11<2340::AID- CNCR7>3.0.CO;2-I 10357403 (Pubitemid 29244841)
3. DR Senger DT Connolly L Van de Water J Feder HF Dvorak 1990 Purification and NH2 terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factors Cancer Res 50 1774 1778 2155059
4. DT Connolly DM Heuvelman R Nelson, et al. 1989 Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis J Clin Invest 84 1470 1478 10.1172/JCI114322 2478587
5. K Maeda YS Chung Y Ogawa, et al. 1996 Prognostic value of vascular endothelial growth factor expression in gastric carcinoma Cancer 77 858 863 10.1002/(SICI)1097-0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-A 8608475 (Pubitemid 26061277)
6. K Inoue Y Ozeki T Suganuma Y Sugiura S Tanaka 1997 Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression Cancer 79 206 213 10.1002/(SICI)1097-0142(19970115)79:2<206::AID-CNCR2>3.0.CO;2-I 9010092 (Pubitemid 27029883)
7. M Toi S Hoshina T Takayanagi T Tominaga 1994 Association of vascular endothelial growth factor expression with tumor angiogenesis and with early release in primary breast cancer Jpn J Cancer Res 85 1045 1049 7525523
8. PJ Paley KA Staskus K Gebhard, et al. 1997 Vascular endothelial growth factor expression in early stage ovarian carcinoma Cancer 80 98 106 10.1002/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A 9210714 (Pubitemid 27270925)
9. G Fontanini S Vignati L Boldrini, et al. 1997 Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma Clin Cancer Res 3 861 865 9815760
10. Y Yonemura Y Endo H Fujita, et al. 1999 Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer Clin Cancer Res 5 1823 1829 10430087
11. N Ferrara T Davis-Smyth 1997 The biology of vascular endothelial growth factor Endocr Rev 18 4 25 10.1210/er.18.1.4 9034784 (Pubitemid 27076453)
12. SA Lang D Klein C Moser, et al. 2007 Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo Mol Cancer Ther 6 1123 1132 10.1158/1535-7163.MCT-06-0628 17363505 (Pubitemid 46554583)
13. G Galizia E Lieto M Orditura, et al. 2007 Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery World J Surg 31 1458 1468 10.1007/s00268-007-9016-4 17516110 (Pubitemid 46945355)
14. R Ito H Nakayama K Yoshida S Matsumura N Oda W Yasui 2004 Expression of Cbl linking with the epidermal growth factor receptor system is associated with tumor progression and poor prognosis of human gastric carcinoma Virchows Arch 444 324 331 10.1007/s00428-004-0982-8 14991403 (Pubitemid 38553636)
15. SP Huang MS Wu HP Wang CS Yang ML Kuo JT Lin 2002 Correlation between serum levels of interleukin-6 and vascular endothelial growth factor in gastric carcinoma J Gastroenterol Hepatol 17 1165 1169 10.1046/j.1440-1746.2002.02873.x 12453275 (Pubitemid 36015611)
16. J Baselga CL Arteaga 2005 Critical update and emerging trends in epidermal growth factor receptor targeting in cancer J Clin Oncol 23 2445 2459 10.1200/JCO.2005.11.890 15753456 (Pubitemid 47050835)
17. J Mendelsohn J Baselga 2003 Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer J Clin Oncol 21 2787 2799 10.1200/JCO.2003.01.504 12860957 (Pubitemid 46606324)
18. A Srivastava GY Lauwers 2008 Gastric epithelial dysplasia: the Western perspective Dig Liver Dis 40 641 649 10.1016/j.dld.2008.02.039 18424243
19. C Fondevila JP Metges J Fuster, et al. 2004 p53 and VEGF expression are independent predictor of tumor recurrence and survival following curative resection of gastric cancer Br J Cancer 90 206 215 10.1038/sj.bjc.6601455 14710231 (Pubitemid 38174963)
20. T Ichikura S Tomimatsu E Ohkura H Mochizuki 2001 Prognostic significance of the expression of vascular endothelial growth factor(VEGF) and VEGF-C in gastriccarcinoma J Surg Oncol 78 132 137 10.1002/jso.1133 11579392 (Pubitemid 32906126)
21. N Tzanakis M Gazouli G Rallis G Giannopoulos I Papaconstantinou G Theodoropoulos 2006 Vascular endothelial growth factor polymorphism in gastric cancer development prognosis, and survival J Surg Oncol 94 624 630 10.1002/jso.20619 17111394 (Pubitemid 44851925)
22. B Obst S Wagner KF Sewing W Beil 2000 Helicobacter pylori causes DNA damage in gastric epithelial cells Carcinogenesis 21 1111 1115 10.1093/carcin/21.6.1111 10836997
23. T Takehana K Kunitomo S Suzuki, et al. 2003 Expression of epidermal growth factor receptor in gastric carcinomas Clin Gastroenterol Hepatol 1 438 445 10.1016/S1542-3565(03)00219-2 15017643 (Pubitemid 37413607)
24. I Garcia F Vizoso A Martin, et al. 2003 Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer Ann Surg Oncol 10 234 241 10.1245/ASO.2003.05.010 12679307 (Pubitemid 40486955)
25. E Mammano C Belluco M Sciro, et al. 2006 Epidermal growth factor receptor(EGFR): mutational and protein expression analysis in gastric cancer Anticancer Res 26 3547 3550 17094480
26. A Gamboa-Dominguez C Dominguez-Fonseca L Quintanilla-Martinez, et al. 2004 Epidermal growth factor receptor expression correlates with poor survival in gastric adenocarcinoma from Mexican patients: a multivariate analysis using a standardized immunohistochemical detection system Mod Pathol 17 579 587 10.1038/modpathol.3800085 15073595 (Pubitemid 38868426)
27. Y Hirono K Tsugawa S Fushida, et al. 1995 Amplification of epidermal growth factor receptor gene and its relationship to survival in human gastric cancer Oncology 52 182 188 10.1159/000227455 7715901
28. J Sanz-Ortega SM Steingerg E Moro 2000 et al. Comparative study of tumor angiogenesis and immunohistochemistry for p53. c-ErbB2, c-myc and EGFR as prognostic factors in gastric cancer Histopathology 15 455 462
29. D McNamara E El-Omar 2008 Helicobacter pylori infection and the pathogenesis of gastric cancer: a paradigm for host-bacterial interactions Dig Liver Dis 40 504 509 10.1016/j.dld.2008.02.031 18486572
30. DA Rappolee D Mark MJ Banda Z Werb 1998 Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping Science 241 708 712 10.1126/science.3041594
31. T Hirano S Akira T Taga T Kishimoto 1990 Biological and clinical aspects of interleukin 6 Immunol Today 11 443 449 10.1016/0167-5699(90)90173-7 2127356
32. R Bataille M Jourdan XG Zhang B Klein 1989 Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias J Clin Invest 84 2008 2011 10.1172/JCI114392 2592570
33. T Tsukamoto Y Kumamoto N Miyao N Masumori A Takahashi M Yanase 1992 Interleukin-6 in renal cell carcinoma J Urol 148 1778 1781 1433606
34. T Seguchi K Yokokawa H Sugao E Nakano T Sonoda A Okuyama 1992 Interleukin-6 activity in urine and serum in patients with bladder carcinoma J Urol 148 791 794 1512827
35. JS Berek C Chung K Kaldi JM Watson RM Knox O Martinez-Maza 1991 Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer Am J Obstet Gynecol 164 1038 1042 2014824
36. C Ravoet J DeGreve K Vandewoude, et al. 1994 Tumor stimulating effects of recombinant human interleukin-6 Lancet 344 1576 1577 10.1016/S0140-6736(94) 90387-5 7983975
37. CW Wu SR Wang MF Chao, et al. 1996 Serum interleukin-6 levels reflect disease status of gastric cancer Am J Gastroenterol 91 1417 1422 8678006
38. K Yoshizaki T Matsuda N Nishimoto, et al. 1989 Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease Blood 74 1360 1367 2788466
39. A Hobisch H Rogatisch A Hittmair, et al. 2000 Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue J Pathol 191 239 244 10.1002/1096-9896(2000)9999: 9999<::AID-PATH633>3.0.CO;2-X 10878544 (Pubitemid 30441246)
40. SP Huang MS Wu CT Shum, et al. 2004 Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma J Biomed Sci 11 517 527 10.1007/BF02256101 15153787